Ibritumomab and Prolixin Decanoate
Determining the interaction of Ibritumomab and Prolixin Decanoate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
Generic Name: fluphenazine
Brand name: Permitil, Prolixin, Prolixin Decanoate, Prolixin Enanthate
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab-Prolixin Oral Concentrate
- Ibritumomab-Proloprim
- Ibritumomab-Promacot
- Ibritumomab-Promacot Injection, Intravenous
- Ibritumomab-Promacta
- Ibritumomab-Promacta (Eltrombopag Powder for Suspension)
- Prolixin Decanoate-Ibritumomab Intravenous
- Prolixin Decanoate-Ibritumomab Tiuxetan
- Prolixin Decanoate-Ibrutinib
- Prolixin Decanoate-Ibrutinib Capsules
- Prolixin Decanoate-Ibrutinib Tablets
- Prolixin Decanoate-Ibu